Eli Lilly Covid Antibody Drug Gets FDA Emergency Clearence

(Bloomberg) -- Eli Lilly & Co.’s antibody therapy was granted an emergency-use authorization by U.S. drug regulators for treating Covid-19, widening access to a treatment that early data suggest is...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.